Latest Blogs

Jan 25, 2021
I’ve been thinking about the word “performance” a lot lately. Why is sexual activity described this way? 
Jan 19, 2021
Do you need to do an advanced fellowship? Dr. Samer Al Hadidi explores the opportunities and drawbacks, and acknowledges that in the current system, the answer is, "It depends."  
Jan 15, 2021
In this new year we must remain alert to our own prejudices, and be vigilant about keeping our personal biases out of the charts and out of our discussions with colleagues, patients, and caregivers. 
Jan 15, 2021
It was clear to chief medical officer Dr. Richard L. Schilsky that ASCO would be his professional home throughout his career. He shares reflections on the role of the Society ahead of his retirement, after 8 years as CMO, in February.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Mar 22, 2012
Earlier this week I passed my friend and colleague, Dr. Ekaterini Tsiapali, in the stairwell. We rarely get to catch up these days, so it was really quite a nice surprise to see her."What...
Mar 10, 2012
I have to admit it. Even today, I find interpreting statistics for patients very difficult; not because I don't understand the concept of relative and absolute risks, hazard or odds ratios, or survival rates. It's because in the end, they do not apply at an individual level.
Feb 11, 2012
The controversy that has erupted regarding the Susan G. Komen foundation and recent decisions about funding Planned Parenthood has been hard to miss. As a specialist in women's cancers and given my general interest in women's health, I've been fascinated by this dialogue online—on message boards,...
Feb 04, 2012
Last week I attended the semi-annual meeting of the Gynecologic Oncology Group, the cooperative group focused on trials for gynecologic cancers. Over two days I was engaged in updates of ongoing clinical trials and discussion of new trial concepts for ovarian,...
Jan 24, 2012
When I tell people I am an oncologist, I usually get the same response: "That must be so depressing! How do you stand it?" I remember having members of my own family ask me that way back when I was a medical resident as I made the decision to enter oncology. Now that I am in a position where I...
Jan 10, 2012
Recently, a very dear friend learned that her breast cancer (diagnosed in 2010) had spread to her brain. Despite my many years as an oncologist, having faced questions from my own patients about "Why me?", "What did I do to deserve this?"—questions I am fully aware have no answer—I found myself...

Pages